Clinical Trials Directory

Trials / Completed

CompletedNCT01481389

The Effect of Theobromine on Blood Lipid Parameters in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Unilever R&D · Industry
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of theobromine on blood lipid parameters in healthy subjects. Secondary objectives are to determine the effect of cocoa and an interaction effect of cocoa and theobromine on blood lipid parameters. Hypothesis: theobromine has a positive effect on blood lipid parameters.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTheobromine200 ml drink with added theobromine (no cocoa added)
DIETARY_SUPPLEMENTCocoa200 ml drink with cocoa (no theobromine added)
DIETARY_SUPPLEMENTCocoa and theobromine200 ml drink with added cocoa and theobromine
DIETARY_SUPPLEMENTPlacebo200 ml drink (no added theobromine or cocoa)

Timeline

Start date
2010-12-01
Primary completion
2011-01-01
First posted
2011-11-29
Last updated
2012-09-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01481389. Inclusion in this directory is not an endorsement.

The Effect of Theobromine on Blood Lipid Parameters in Healthy Subjects (NCT01481389) · Clinical Trials Directory